Nandi Chen

Title: Nandi Chen: Innovator in Radiolabeling Technology

Introduction

Nandi Chen is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of radiolabeling technology, particularly in the development of compounds used in medical treatments. His innovative approach has led to the creation of a unique patent that showcases his expertise and dedication to advancing scientific research.

Latest Patents

Nandi Chen holds a patent for a method titled "One-step, fast, 18F-19F isotopic exchange radiolabeling of difluoro-dioxaborinins and use of such compounds in treatment." This patent describes a compound according to Formula (I) or a pharmaceutically acceptable salt and/or solvate thereof. The compound features various substituents, including alkyl, amine, perfluoroalkyl, alkenyl, alkynyl, aryl, or aralkenyl groups. The versatility of these compounds allows for significant applications in therapeutic settings.

Career Highlights

Throughout his career, Nandi Chen has worked with esteemed institutions such as Cornell University and Memorial Sloan Kettering Cancer Center. His experience in these organizations has provided him with a solid foundation in research and development, enabling him to push the boundaries of innovation in his field.

Collaborations

Nandi Chen has collaborated with notable professionals, including Richard Ting and Omer Aras. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in technology.

Conclusion

Nandi Chen's contributions to radiolabeling technology exemplify his commitment to innovation and scientific progress. His patent and collaborations highlight his role as a key figure in the advancement of medical treatments.